Cargando…

Technical challenges and limitations of current mouse models of ovarian cancer

The development of genetically engineered models (GEM) of epithelial ovarian cancer (EOC) has been very successful, with well validated models representing high grade and low grade serous adenocarcinomas and endometrioid carcinoma (EC). Most of these models were developed using technologies intended...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garson, Kenneth, Gamwell, Lisa F, Pitre, Elizabeth MG, Vanderhyden, Barbara C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537528/ https://www.ncbi.nlm.nih.gov/pubmed/23190474 http://dx.doi.org/10.1186/1757-2215-5-39

Ejemplares similares

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population
por: McCloskey, Curtis W., et al.
Publicado: (2014)

PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer
por: Alwosaibai, Kholoud, et al.
Publicado: (2022)

GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
por: Hodgkinson, Kendra, et al.
Publicado: (2018)

Optimization of lentiviral vector production using polyethylenimine-mediated transfection
por: TANG, YONG, et al.
Publicado: (2015)

Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium
por: Carter, Lauren E., et al.
Publicado: (2021)

Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics
por: Gamwell, Lisa F, et al.
Publicado: (2013)

PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming
por: Feng, Yan, et al.
Publicado: (2020)

PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
por: Alwosaibai, Kholoud, et al.
Publicado: (2017)

Ovarian cancer mouse models: a summary of current models and their limitations
por: Fong, Miranda Y, et al.
Publicado: (2009)

Animal models of ovarian cancer
por: Vanderhyden, Barbara C, et al.
Publicado: (2003)

Limitations of Current in Vivo Mouse Models for the Study of Chikungunya Virus Pathogenesis
por: Chan, Yi-Hao, et al.
Publicado: (2015)

Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium
por: Abedini, Atefeh, et al.
Publicado: (2020)

The significance of ovarian fibrosis
por: Landry, David A., et al.
Publicado: (2020)

LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
por: Mehdi, Sadia, et al.
Publicado: (2020)

Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
por: McCloskey, Curtis W., et al.
Publicado: (2018)

Current methodological and technical limitations of time and volumetric capnography in newborns
por: Schmalisch, Gerd
Publicado: (2016)

Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer
por: Cook, David P., et al.
Publicado: (2023)

Astrocyte Heterogeneity in Multiple Sclerosis: Current Understanding and Technical Challenges
por: Lo, Chih Hung, et al.
Publicado: (2021)

Targeting TBP-Associated Factors in Ovarian Cancer
por: Ribeiro, Jennifer R., et al.
Publicado: (2014)

The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research
por: Rodriguez, Galaxia M., et al.
Publicado: (2022)

Sleep apps: current limitations and challenges
por: Ananth, Sachin
Publicado: (2021)

17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
por: Vuong, Nhung H., et al.
Publicado: (2017)

Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth
por: Thomas, Fiona H, et al.
Publicado: (2006)

Skeletal muscle proteomics: current approaches, technical challenges and emerging techniques
por: Ohlendieck, Kay
Publicado: (2011)

Current Technical Approaches for the Early Detection of Foodborne Pathogens: Challenges and Opportunities
por: Cho, Il-Hoon, et al.
Publicado: (2017)

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
por: Sheta, Razan, et al.
Publicado: (2019)

Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model
por: Pépin, David, et al.
Publicado: (2011)

Exploring the invisible: art, science, and the spiritual
por: Gamwell, Lynn
Publicado: (2020)

Mathematics and art: a cultural history
por: Gamwell, Lynn
Publicado: (2016)

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Technical approaches for mouse models of human disease
por: Justice, Monica J., et al.
Publicado: (2011)

Current Non-Contact Road Surface Condition Detection Schemes and Technical Challenges
por: Ma, Yao, et al.
Publicado: (2022)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

HL Technical challenges
por: BEJAR ALONSO, Isabel
Publicado: (2014)

Clinical applications and limitations of current ovarian stem cell research: a review
por: Hutt, Karla J, et al.
Publicado: (2006)

Keyhole approach in anterior circulation aneurysm: Current indication, advantages, technical limitations, complications and their avoidance
por: Prajapati, Hanuman, et al.
Publicado: (2022)

A timely reminder of technical limitations
por: Prosser, James I.
Publicado: (2016)

Current-limiting challenges for all-spin logic devices
por: Su, Li, et al.
Publicado: (2015)

The challenges of diagnosing osteoporosis and the limitations of currently available tools
por: Choksi, Palak, et al.
Publicado: (2018)

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
por: Farokhi Boroujeni, Salar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f9hvfuldf9l1da989etbm0h9ue